Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-063803

Chief Scientific Officer gave up 412 shares (to pay taxes)

  • Chief Scientific Officer acquired 1,450 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Shanler Stuart · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-12-18 Exercise or conversion : show line 1 in the form +1,450 269,892 D
2018-12-18 Shares withheld for taxes : show line 2 in the form −412 $6.30 $2,596 269,480 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-12-18 Exercise or conversion : show line 3 in the form Restricted Stock Units −1,450 1,450 D
Loading xslF345X03/doc4.xml…